Brussels, 10/12/2001 (Agence Europe) - On the basis of a report on the health risks associated with the use of PMMA (paramethoxymethylamphetamine or N-methl-1-4-(methaoxyphenyl)-2-aminopropane), prepared by a meeting of experts from the Member States under the auspices of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, the European Commission decided on Friday to present an initiative to the Council to make PMMA subject to control measures in all...